about
Characterization of endogenous human promyelocytic leukemia isoformsPrognostic value of histologic features of toxic epidermal necrolysis.Eruptive disseminated superficial basal cell carcinomas 24 years after bone marrow transplantation.Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides.Fungal skin and soft tissue infections.Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.Fibroblastic rheumatism: immunosuppressive therapy is not always required.[Severe necrotic and haemorrhagic edema of the upper limbs revealing remitting seronegative symmetrical synovitis with pitting edema]Bipolar hypertrophic herpes: an unusual presentation of acyclovir-resistant herpes simplex type 2 in a HIV-infected patient.Clonogenic cell subpopulations maintain congenital melanocytic nevi.BRAF V600 inhibitor discontinuation after complete response in advanced melanoma: a retrospective analysis of 16 patients.Ustekinumab as Effective Treatment for Refractory Amicrobial Pustulosis of the Folds Associated with Crohn's Disease.Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis.[A glioblastoma reveals tuberous sclerosis complex].Locally Advanced Unresectable Vaginal Melanoma: Response With Anti-Programmed Death Receptor 1.NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.T cell polarity at the immunological synapse is required for CD154-dependent IL-12 secretion by dendritic cells.Limited functional capacity of microchimeric fetal hematopoietic progenitors acquired by mothers during pregnancyPerformance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysisPopulation Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic MelanomaEncephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective studyIncreased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study
P50
Q24293678-27172263-6D8B-45EB-845D-76C7E0B1FBE4Q37956766-7B33D801-9643-4356-8697-D9D133681DA8Q38287419-C52FE77E-138A-4F85-A63D-CD90FC63F33BQ38439673-81C3DE0F-9622-46CF-89F7-83BF72E585C3Q38749990-9C1BF8ED-6D75-4E2C-9383-A5D3FE229AF9Q39755837-79C41E3B-53B5-4B99-BE47-5EE2FC5903F6Q40142823-471638A6-AE4B-4EB1-A44D-77A8E60B60DAQ40466057-4545D1EC-631F-4937-99F6-7DF082849ED3Q43254414-1B4E0635-DF94-4A7B-A089-EF391E251282Q44490396-C545F44C-E178-48D2-AD2B-8FCC303118D8Q48303056-6E731E51-39E1-404B-9A67-D0F7D4B95A0FQ51410913-46413059-3DC4-4C9E-A967-7DAD7FD07BBDQ51486345-752BA2A4-8DA0-4029-B127-9491E50C19C5Q53179946-CDA16311-7A85-44E6-9CFF-841EB80CE08BQ53231318-FDBC7143-FA49-4679-8C0D-BD3BFFD0E6D3Q54239316-3607EC67-EF80-42EA-B977-5C854E24BC3EQ54637817-AE0410E1-C601-4FBA-959B-4D87ED245ABDQ57913892-33FBB3FD-9FAF-4539-BFA6-B96733B3A15EQ82066745-5C62CC5F-0757-4DD7-A550-FD64DCC7D5CAQ91869819-8F764899-52E0-4B5B-A0C4-39F0BFC9E571Q92895552-23AC1025-8A36-4260-86C6-3474E5473D94Q96291088-6EDDE8F9-B680-46BF-9E3E-BBA1784A2918
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sarah Guegan
@ast
Sarah Guegan
@en
Sarah Guegan
@es
Sarah Guegan
@nl
type
label
Sarah Guegan
@ast
Sarah Guegan
@en
Sarah Guegan
@es
Sarah Guegan
@nl
prefLabel
Sarah Guegan
@ast
Sarah Guegan
@en
Sarah Guegan
@es
Sarah Guegan
@nl
P106
P21
P31
P496
0000-0001-5400-1939